Technical Analysis of Stocks: SPY / QQQ / NVDA / TSLA / AMD / PLTR
4 extracted signals · 4 resolved · 0 still active
The Finance HydraIndependent analyst profile- Source published
- 12 Aug 2026, 23:36 UTC
- Recorded by Tahlil Plus
- 13 Aug 2026, 01:05 UTC

AI-generated source summary
The speaker analyzes SPY, QQQ, NVDA, and TSLA using daily charts. SPY and QQQ are observed to be consolidating within range-bound structures, with SPY trading between 776.56 and 767.67, and QQQ between 725.08 and 709.39. The speaker notes a triple support level for QQQ near 709.39. NVDA shows a bullish bias, having successfully retested its 1-hour and 1-day EMAs and showing strength, with a potential target around 233.52. However, the speaker advises caution due to upcoming earnings. TSLA is identified as being in a bearish trend, with a clear break below its 21-period EMA on the 1-hour chart and a bearish candle pattern forming. The speaker suggests selling TSLA near resistance levels around 350.49 or 339.57, with potential downside targets near 327.51 or even 308.50.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
4 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
The Finance Hydra
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.



